Pharmaceuticals

Urea Cycle Disorders Treatment Market Size and Demand Forecast 2026–2030

February 27, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the urea cycle disorders treatment market from 2026–2035 with trusted insights from The Business Research Company

What growth pattern is forecast for the Urea Cycle Disorders Treatment Market size between 2026 and 2035?

The urea cycle disorders treatment market has observed steady expansion in recent years. Its value is projected to rise from $1.37 billion in 2025 to $1.43 billion in 2026, with a compound annual growth rate (CAGR) of 3.8%. Historically, this market’s growth can be attributed to aspects such as limited awareness of UCD, a restricted array of treatment choices, low patient diagnosis rates, elevated treatment costs, and a reliance on hospital-based care.

The urea cycle disorders treatment market is expected to show steady expansion in the coming years. Its size is forecast to reach $1.71 billion by 2030, driven by a compound annual growth rate (CAGR) of 4.6%. This anticipated growth can be linked to the rise in gene therapy research, the growing acceptance of precision medicine, technological improvements in ammonia monitoring, an increased focus on pediatric patients, and the expansion of home healthcare services. Significant trends projected for this period encompass the creation of personalized UCD therapies, better ammonia scavenger formulations, breakthroughs in enzyme replacement therapy, innovations in pediatric-focused treatments, and the emergence of home-based and remote monitoring solutions.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12237&type=smp

Which Drivers Are Impacting Market Performance In The Urea Cycle Disorders Treatment Market?

The projected increase in chronic kidney disorder instances is expected to stimulate the growth of the urea cycle disorders treatment market going forward. Chronic kidney disease (CKD) is a persistent condition marked by a gradual deterioration of kidney function over time. Chronic kidney disorder necessitates urea cycle disorder treatment to manage metabolic waste, particularly elevated levels of urea, as impaired kidney function hampers proper waste excretion. For instance, in November 2023, according to Kidney Care UK, a UK-based kidney patient support charity, an estimated 7.2 million individuals have chronic kidney disease (CKD) stages 1–5, with about 3.5 million people in the UK experiencing the later stages of CKD (stages 3-5), during which symptoms are anticipated to become progressively harder to control. Therefore, the rising number of chronic kidney disorder cases is driving the growth of the urea cycle disorders treatment market.

What Segment Types Are Examined In The Urea Cycle Disorders Treatment Market?

The urea cycle disorders treatment market covered in this report is segmented –

1) By Treatment: Amino Acid Supplements, Sodium Phenylbutyrate, Glycerol Phenylbutyrate, Sodium Benzoate, Other Treatments

2) By Enzyme Deficiency: Ornithine Transcarbamylase (OTC), Argininosuccinate Synthetase (AS), Arginase (AG), Argininosuccinate Lyase (AL), Carbamoyl Phosphate Synthase (CPS1)

3) By Route of Administration: Oral, Injectables

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Amino Acid Supplements: Arginine Supplements, Citrulline Supplements, Other Essential Amino Acids

2) By Sodium Phenylbutyrate: Powder Form, Tablet Form

3) By Glycerol Phenylbutyrate: Oral Solutions, Other Forms

4) By Sodium Benzoate: Intravenous Solutions, Oral Formulations

5) By Other Treatments: Liver Transplantation, Dietary Modifications, Enzyme Replacement Therapy, Other Supportive Therapies

How Are New Market Trends Shaping The Landscape Of The Urea Cycle Disorders Treatment Market?

Leading companies within the urea cycle disorder treatment industry are increasingly adopting strategic partnership approaches to foster innovative therapies and enhance disease management. These strategic collaborations involve businesses leveraging each other’s strengths and resources to achieve mutual benefits and shared success. For example, in June 2024, Orsini Specialty Pharmacy, a US-based provider of personalized care and medications, and Zevra Therapeutics Inc., a US-based rare disease therapeutics company, announced that Orsini would serve as the pharmacy partner for OLPRUVA (sodium phenylbutyrate) oral suspension. OLPRUVA is a prescription medicine prescribed alongside specific therapies, including dietary modifications, for the long-term management of urea cycle disorders (UCDs) in certain adult and pediatric patients diagnosed with deficiencies in carbamylphosphate synthetase (CPS), ornithine transcarbamylase (OTC), or argininosuccinic acid synthetase (AS).

Who Are The Core Companies Influencing Trends In The Urea Cycle Disorders Treatment Market?

Major companies operating in the urea cycle disorders treatment market are Bausch Health Companies Inc., Recordati Rare Diseases, Eurocept Pharmaceuticals Holding, Acer Therapeutics, Ultragenyx Pharmaceutical, Aeglea BioTherapeutics, Arcturus Therapeutics Inc., Orpharma Pty Ltd., Horizon Therapeutics Plc, Synlogic, Amicus Therapeutics, Sobi, PTC Therapeutics, Chiesi Farmaceutici S.p.A., Astellas Pharma Inc., Protalix BioTherapeutics, Erytech Pharma, Relief Therapeutics Holding AG, Selecta Biosciences Inc., Argenx SE, Dynacure SA, Inventiva SA

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/urea-cycle-disorders-treatment-global-market-report

Which Regions Are Projected To Dominate The Urea Cycle Disorders Treatment Market In The Coming Years?

North America was the largest region in the urea cycle disorders treatment market in 2025. The regions covered in the urea cycle disorders treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Urea Cycle Disorders Treatment Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12237&type=smp

Browse Through More Reports Similar to the Global Urea Cycle Disorders Treatment Market 2026, By The Business Research Company

Urea Cycle Disorders Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/urea-cycle-disorders-treatment-global-market-report

Urology Supplements Market Report 2026

https://www.thebusinessresearchcompany.com/report/urology-supplements-global-market-report

Urea Market Report 2026

https://www.thebusinessresearchcompany.com/report/urea-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795